At a glance
ClinicalIndex Comparison RecordN/ACompleted· 384 enrolled
Drug / intervention
Argon Plasma Coagulation +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Prospective Randomized Controlled Trial Describing the Recurrence Rate of Adenomas in Sessile or Flat Colonic Lesions 15mm or Larger Receiving Post-resection Site Treatment With Snare Tip Soft Coagulation or Argon Plasma Coagulation
In Brief
A clinical study evaluating Argon Plasma Coagulation and Snare Tip Soft Coagulation for Recurrence. Completed, enrolled 384 participants across 10 sites.
Detailed Summary
Patients who have provided informed consented and are scheduled to undergo endoscopic mucosal resection (EMR) of lesions 15mm and larger will be randomized to STSC (80 W, Effect 5) vs APC (preferred settings) vs No Treatment of the perimeter of the EMR site.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsRecurrence
CountriesUnited States
CollaboratorsErbe USA Incorporated
Timeline
N/ACompletedFinished
20192020202120222023202420252026
First PostedAug 2018
Enrollment StartOct 2018
Primary CompletionDec 2022
TodayJul 2026
First PostedAug 31, 2018
Enrollment StartOct 16, 2018
Primary CompletionDec 14, 2022
TodayJul 2, 2026
Enrollment to primary: 4.2 yearsPosted 7.8 years ago
Interventions
Argon Plasma Coagulationdevice
APC will be applied to the perimeter of the resection site
Snare Tip Soft Coagulationdevice
STSC will be applied to the perimeter of the resection site